Trials / Completed
CompletedNCT00818194
Comparison of Extended Release Tacrolimus (Advagraf) and Cyclosporine A Microemulsion on Renal Function in Healthy Volunteers
A Comparison of Effects of Short-term Low Dose Exposure of Advagraf® and Neoral® Microemulsion Cyclosporine A on Renal Perfusion and Function in Healthy Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 18 (actual)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- Male
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to compare the effects of steady state tacrolimus vs. cyclosporine on renal pharmacodynamics in healthy volunteers.
Detailed description
This study seeks to evaluate the renal physiological responses of short-term maintenance level doses of CNIs in healthy volunteers to determine if daily perturbations in renal physiology exist, and if confirmed, whether they differ between CNIs and thus may contribute by different mechanisms to the progression of CAN.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | extended release tacrolimus | oral |
| DRUG | cyclosporine A microemulsion | oral |
Timeline
- Start date
- 2008-04-01
- Primary completion
- 2008-09-01
- Completion
- 2008-09-01
- First posted
- 2009-01-07
- Last updated
- 2014-07-09
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT00818194. Inclusion in this directory is not an endorsement.